1048 related articles for article (PubMed ID: 25919171)
1. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
Jauregui B; Garcia AG; Bess Janusz C; Blau J; Munier A; Atherly D; Mvundura M; Hajjeh R; Lopman B; Clark AD; Baxter L; Hutubessy R; de Quadros C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1(0 1):A28-33. PubMed ID: 25919170
[TBL] [Abstract][Full Text] [Related]
3. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
[TBL] [Abstract][Full Text] [Related]
4. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.
Toscano CM; Jauregui B; Janusz CB; Sinha A; Clark AD; Sanderson C; Resch S; Ruiz Matus C; Andrus JK;
Vaccine; 2013 Jul; 31 Suppl 3():C12-8. PubMed ID: 23777685
[TBL] [Abstract][Full Text] [Related]
5. The ProVac initiative and evolving decision support.
Sanderson CF
Vaccine; 2015 May; 33 Suppl 1():A8-10. PubMed ID: 25919181
[No Abstract] [Full Text] [Related]
6. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country.
Molina-Aguilera IB
Vaccine; 2015 May; 33 Suppl 1():A6-7. PubMed ID: 25919176
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness of pneumococcal conjugate vaccination in Georgia.
Komakhidze T; Hoestlandt C; Dolakidze T; Shakhnazarova M; Chlikadze R; Kopaleishvili N; Goginashvili K; Kherkheulidze M; Clark AD; Blau J
Vaccine; 2015 May; 33 Suppl 1():A219-26. PubMed ID: 25919165
[TBL] [Abstract][Full Text] [Related]
10. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.
Andrus JK; Walker DG
Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161
[No Abstract] [Full Text] [Related]
12. Descriptive analysis of immunization policy decision making in the Americas.
Burns JE; Mitrovich RC; Jauregui B; Matus CR; Andrus JK
Rev Panam Salud Publica; 2009 Nov; 26(5):398-404. PubMed ID: 20107690
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools.
Chaiyakunapruk N; Somkrua R; Hutubessy R; Henao AM; Hombach J; Melegaro A; Edmunds JW; Beutels P
BMC Med; 2011 May; 9():53. PubMed ID: 21569402
[TBL] [Abstract][Full Text] [Related]
14. Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes.
Sosler S; Kallenberg J; Johnson HL
Vaccine; 2015 May; 33 Suppl 1():A4-5. PubMed ID: 25919172
[No Abstract] [Full Text] [Related]
15. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
16. Foreword.
Etienne CF
Vaccine; 2015 May; 33 Suppl 1():A1. PubMed ID: 25919148
[No Abstract] [Full Text] [Related]
17. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M
Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013.
Sibak M; Moussa I; El-Tantawy N; Badr S; Chaudhri I; Allam E; Baxter L; Abo Freikha S; Hoestlandt C; Lara C; Hajjeh R; Munier A
Vaccine; 2015 May; 33 Suppl 1():A182-91. PubMed ID: 25919159
[TBL] [Abstract][Full Text] [Related]
19. Systematic documentation of new vaccine introduction in selected countries of the Latin American Region.
de Oliveira LH; Toscano CM; Sanwogou NJ; Ruiz-Matus C; Tambini G; Roses-Periago M; Andrus JK
Vaccine; 2013 Jul; 31 Suppl 3():C114-22. PubMed ID: 23777684
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rotavirus vaccination in Albania.
Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
